top of page
AdobeStock_267643347_edit_edited_edited_edited_edited.png

Track Record

Healthcare & Life Sciences

Our Healthcare and  Life Sciences M&A Advisory Practice is built on over 20 years of experience supporting clients across a diverse range of healthcare verticals, including pharmaceuticals, diagnostics, software, medtech, and services.

 

During this time, we have navigated multiple phases of industry evolution, from consolidation and globalisation through to the increasing integration of technology, data, and personalised care.

 

This long-standing sector focus gives us a deep understanding of the strategic drivers shaping transactions, as well as the regulatory, clinical, and commercial dynamics unique to healthcare. We maintain strong, established relationships with many of the leading global acquirers, private equity investors, and growth capital providers active in the sector.

 

Combined with our insight into emerging trends, from digital health to advanced therapeutics, we are well positioned to help clients anticipate market shifts, position their businesses effectively, and execute transactions that maximise value in an increasingly complex and fast-evolving landscape.

Success Story

Man-on-mountain3-window-e1758591508514-1819x2048.jpg

About Innovative Edge (IE): A market leading SaaS Platform for Pharmaceutical Launch management with a services wrapper

About Lumanity: Lumanity through its team of 1200 experts combines scientific, clinical, medical, regulatory, and commercial expertise with advanced technology and AI-based tools to provide end-to-end commercialization support.

Healthcare M&A

March 2022

ScMg1j5TD87XTnpu38uM9U7wVp81654678941452_200x200.png

Sold To

Lumanity_Logo_4Color-png.png

Narrative: Whilst looking to understand the value of his business and the potential paths to selling it, IE founder, Steve Marsh, came to Bean Partners to gain more insight on what options and strategies existed. 

 

After some very detailed preparation work and implementation of key initiatives, Bean Partners went to market for the sale with US Private Equity backed Lumanity identified as the right buyer.  Not only was the value well above benchmark but the structure had a very high proportion of cash up front giving Steve a very strong and clean outcome.

Innovative Edge Founder and CEO, Steve Marsh: "Despite the words of warnings from friends, CEO colleagues, and other advisors, about the perils and stresses of the process - those stresses never materialised. I honestly believe that this is due to the way Bean Partners integrated themselves into the process, proactively navigating me and taking real ownership of all key aspects."

Bean Partners Logo 2023_Light.png

hello@beanpartners.com

+44 20 7931 9500

Terms & Conditions  |  Privacy Policy  |  Cookies

© 2024 Bean Partners Ventures Limited

London, United Kingdom

Toronto, Canada

 

Perth, Australia

Legal and regulatory information
Bean Partners Ventures Limited is an Appointed Representative of Capital Systematics Ltd, which is authorised and regulated by the Financial Conduct Authority. The contents of this website are provided for information purposes only and do not constitute either an offer to sell or invitation or solicitation of an offer to buy any security, or investment advice.  Any information that may relate to investments is directed solely at investment professionals and exempt persons as defined by the Financial Services and Markets Act (2000) and subsequent Orders and amendments.  Bean Partners Ventures makes no representation or warranty as to the accuracy, reliability, or completeness of the information contained in this website, and said information may not be relied upon in connection with any investment decision.   This website is directed solely to the intended recipient and may not be copied, reproduced, distributed, disclosed or published, in whole or in part, to any other person for any purpose without prior written consent.  Bean Partners Ventures Limited is registered in England and Wales, number 13992410, registered address 14-15 Lower Grosvenor Place, London, England, SW1W 0EX.
bottom of page